OPAF Care Connect

The Otsuka Patient Assistance Foundation, Inc. (OPAF) is a 501c(3) nonprofit organization that provides eligible uninsured or underinsured patients with prescribed Otsuka medication free of cost. The OPAF mission is to improve the health & wellness for eligible patients by reducing barriers to healthy living and enabling patients along their health journeys.

Are you a Patient or Caregiver?

We encourage you to apply and let a dedicated Patient Access Advocate do an in-depth eligibility analysis for you. You can contact a dedicated Patient Access Advocate at 1-855-727-6274 (Monday-Friday 8am - 6pm ET, excluding National Holidays) with questions.

Register/Login

Are you a Healthcare Provider?

You can complete applications on behalf of patients with access barriers or those who are uninsured or underinsured. Apply online through the OPAF Care Connect Portal.

Register/Login

When you sign up for the OPAF Care Connect Portal, you can:

Prescription order submission and tracking for:

ABILIFY MAINTENA® (aripiprazole) extended release injectable suspension
ABILIFY ASIMTUFII® (aripiprazole) extended-release injectable suspension
NUEDEXTA® (Dextromethorphan HBr and Quinidine Sulfate) capsules
JYNARQUE® (tolvaptan) tablets
REXULTI® (brexpiprazole) tablets

Access prescription template for e-prescribing.

Submit prescriptions to our partner pharmacy: Eversana Life Science Services

For states that require eScribe, please submit a prescription via your EMR system to Eversana Life Science Services, 17877 Chesterfield Airport Road, Chesterfield, MO 63005. by Phone at 1-855-727-6274 or by Fax at 1-844-727-6274 during business hours: Monday-Friday, 8am to 6pm ET.

See GLOBAL FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.
See MEDICATION GUIDES for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.

Enrollment Application for ABILIFY MAINTENA®
(aripiprazole) extended-release injectable suspension

Download

Enrollment Application for ABILIFY ASIMTUFII®
(aripiprazole) extended-release injectable suspension

Download

Enrollment Application for REXULTI®
(brexpiprazole) tablets

Download

Enrollment Application for NUEDEXTA®
(dextromethorphan HBr and quinidine sulfate) capsules

Download

Enrollment Application for JYNARQUE®
(tolvaptan) tablets

Download

Frequently Asked Questions

If the Eligibility tool indicates that I may be eligible, can I submit an application?

Yes, you can begin the application process by applying via the OPAF Care Connect Patient Portal. The OPAF team will work with your healthcare professional [HCP] to finish the application process. When submitting your information into the portal, please be sure to upload all of the required documentation such as income verification, U.S. home address verification, and insurance denial information.

Get Answers to other FAQ

Have questions about OPAF and don’t have time for a phone call?

Send a secure message directly to a dedicated OPAF Patient Access Advocate.

Send a secure message

Supported Medications

OPAF provides eligible patients no-cost support for the following prescribed medications:

See GLOBAL FULL PRESCRIBING INFORMATION for NUEDEXTA and VOYXACT.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.
See MEDICATION GUIDES for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.

Secure messaging ensures patient privacy because it is a HIPAA-compliant, password-protected electronic messaging platform. You can communicate directly with an OPAF Patient Access Advocate without having to pick up the phone. Through the platform you can securely send electronic messages with any questions, communications, and documents at your convenience.

Because it is HIPAA-compliant, there is a one-time account activation process. The activation process takes less than 3 minutes. Once your account is active, you can send messages to OPAF immediately.

To setup your OPAF secure message account follow the steps below:

Click on the (button or envelope) below to start the process
The system will prompt you to enter your email address as a "New to SecureContact"
A verification email will be sent to the email address that you entered
In your email inbox, you will find a message from "[email protected]"
Open this message and click on the link to activate your account
Complete the account activation by creating a password
Your account is active, and you can securely send a message to OPAF

If you have any questions, please contact OPAF at 1-855-727-6274 (Monday-Friday 8am - 6pm ET, excluding National Holidays)

MESSAGE US

message

OPAF Care Connect

Are you a Patient or Caregiver?

Are you a Healthcare Provider?

When you sign up for the OPAF Care Connect Portal, you can:

Frequently Asked Questions

If the Eligibility tool indicates that I may be eligible, can I submit an application?

Have questions about OPAF and don’t have time for a phone call?

Supported Medications

Secure Messaging

Welcome to the Otsuka Patient Assistance Foundation, Inc.

WELCOME TO THE OTSUKA PATIENT ASSISTANCE FOUNDATION, INC. OPAF ENGAGEMENT CENTER SCHEDULE UPDATE

WELCOME TO THE OTSUKA PATIENT ASSISTANCE FOUNDATION, INC.
OPAF ENGAGEMENT CENTER SCHEDULE UPDATE